other material
confidence high
sentiment neutral
materiality 0.70
RenovoRx raises $5M in registered direct offering and private placement of common stock and warrants
RenovoRx, Inc.
- Gross proceeds of ~$5M from sale of 1,557,632 shares (or pre-funded warrants) at $3.21 per share.
- Concurrent private placement of warrants to purchase 1,947,040 shares at $3.21, exercisable for 5.5 years.
- Offering priced at-the-market under Nasdaq rules; closing on April 3, 2023.
- Roth Capital Partners acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
- Pre-funded warrants priced at $3.2099 each to avoid investor exceeding 4.99% beneficial ownership.